Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Postoperative Pain After Open Thoracotomy
NCT05172570Phase 3Terminated
- Sponsor
- Indiana University
- Start
- Apr 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of gabapentin in postoperative pain (3 arms), sponsored by Indiana University. Primary endpoint: Incision and Chest Tube Site Pain Scores at 96 hours. Started Apr 2021; status: terminated.
02
Drugs
gabapentin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05172570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05172570.